Secondary screening

Focused screening

Fluofarma has developed a panel of assays for focused secondary screening in cell-based models of human diseases or in primary cell cultures. Our cell-based models enable reliable, targeted screening for a specific pathology.

Example of secondary screening in neurobiology

Fluofarma developed cellular models that mimic neurodegenerative disease. Those models are based on primary cultures of neurons grown in presence of neurodegeneration inducers.

As shown by the Figure below, focused screenings using those models allow the identification of drugs able to delay the neurodegeneration process (green).

 

Example of secondary screening in oncology

Fluofarma has a large panel of cancer cell lines which are representative of the major tumor types, as well as engineered cell lines overexpressing specific targets for more focused screening.

These cell-based tools enable allow the identification of drugs which act on a specific cancer type or a specific target.



Download Neurobiology.pdf
Download Oncology.pdf

Breaking news

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal Cell Research.

    Read more [+]

  • Publication

    Fluofarma cited in a Biocompare featured article “Flow Cytometry Gets a Makeover”

    Read more [+]

  • Press Release

    Roche adopts Fluofarma’s high-content screening platform.

    Read more [+]

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal "Analytical Chemistry".

    Read more [+]

  • ECCP 2010

    Fluofarma will be attending the European Cancer Cluster Partnering 2010 in Oslo, from September 15th to 17th.

    Read more [+]

  • BIO-Connexion Congress

    Fluofarma will be attending the Bio-Connexion Congress in Paris, from October 6th to 7th.

    Read more [+]

  • 22nd EORTC-NCI-AACR symposium

    Fluofarma will be exhibitor at the 22nd EORTC-NCI-AACR symposium in Berlin from November 16th to 19th.

    Read more [+]

Roche adopts Fluofarma’s platform
October 19, 2009 – Fluofarma announced today that it entered into a multi-year agreement with Roche.
Read More



ALL NEWS